Detailed price information for Astrazeneca Plc ADR (AZN-Q) from The Globe and Mail including charting and trades.

Big shakeups may be coming to the childhood vaccination schedule. Here's a look at some of the shots that could be subject to ...

The global Vaccines Market, valued at US$59.52 billion in 2024, stood at US$50.46 billion in 2025 and is projected to advance at a ...

We recently compiled a list of the 10 High Growth Pharma Stocks That Are Profitable in 2025. Merck & Co., Inc. stands third among them. Merck & Co., Inc. (NYSE:MRK), a global leader in pharmaceuticals ...

Coupled with headwinds in China, Merck is also seeing lower demand for Gardasil in Japan. Sales are expected to remain weak in Japan in the second half of 2025. Our estimates for Gardasil sales ...

Real-world study data showed that the monoclonal antibody nirsevimab was highly effective at preventing severe respiratory ...

Oncologists and scientists warn that extensive cuts to mRNA funding will have devastating impacts on cancer vaccine ...

ACOG released updated clinical guidance on vaccination for COVID-19, respiratory syncytial virus and influenza during ...

Merck KGaA has swooped into a neurological-focused pact with RNA biotech Skyhawk Therapeutics that could top out at $2 billion.